The challenges of breast cancer care in Mexico during health-care reforms and COVID-19
2021 · The Lancet Oncology · 17 citations
https://doi.org/10.1016/s1470-2045(20)30609-4
A
Ana S. Ferrigno
Yale University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
684
Citations
13
h-index
16
i10-index
Ana S. Ferrigno is an academic researcher from Yale University. The author has contributed to research in topics: BRCA gene mutations in cancer & Breast Cancer Treatment Studies & Cancer survivorship and care. The author has an h-index of 13, co-authored 67 publications.
ORCID: 0000-0003-1855-1196Papers by this author
worksAdjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
2021 · The Breast · 10 citations
https://doi.org/10.1016/j.breast.2021.05.013
Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review
2024 · BMC Cancer · 8 citations
https://doi.org/10.1186/s12885-023-11704-6
Molecular Subtype Discordance in a Young Woman with Synchronous Bilateral Breast Cancer: A Case Report
2020 · Cureus · 3 citations
https://doi.org/10.7759/cureus.7242
Support and care needs among Mexican women with metastatic breast cancer
2025 · Supportive Care in Cancer · 0 citations
https://doi.org/10.1007/s00520-025-09529-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat